Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 Mga view
• 07/18/23
0
0
I-embed
administrator
Mga subscriber
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento